A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine when Administered Concomitantly with Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Adults
Phase of Trial: Phase III
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate
- Indications Hepatitis A; Hepatitis B; Meningococcal infections
- Focus Pharmacodynamics; Registrational
- Sponsors Novartis
- 02 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.